Evidence map›Paper›PMID 39758979›Full record

ArticlePolicy insights from the behavioral and brain sciences2023

Endocrine-Disrupting Chemicals: Science and Policy.

Emily N Hilz, Andrea C Gore

Abstract read
In one paragraph

Article in Policy insights from the behavioral and brain sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Expression of the Human R163C-International journal of molecular sciences · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Oestrogenic and androgenic activity of oxybenzone and methylparabenArhiv za higijenu rada i toksikologiju · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Occurrence and sources of hormones in water resources-environmental and health impact.Environmental science and pollution research international · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emily N HilzThe University of Texas, Austin, TX, USA.
Andrea C GoreThe University of Texas, Austin, TX, USA.ORCID 0000-0001-5549-6793

Funding

Environmental Epigenetics of EDCs: From Germline to BrainR35ES035024 · NIEHS · UNIVERSITY OF TEXAS AT AUSTIN · PI Andrea C Gore · 2023 to 2026
$3.1M
Endocrine Disruption of the Developing Dopamine SystemF32ES034257 · NIEHS · UNIVERSITY OF TEXAS AT AUSTIN · PI HILZ, EMILY NICOLE · 2023 to 2025
$193k
NIEHS NIH HHS F32 ES034257NIEHS NIH HHS R35 ES035024
6 · The paper itself

Abstract

Endocrine-disrupting chemicals (EDCs) are chemicals that disrupt the normal functioning of endocrine system hormones, leading to a range of adverse health effects in humans and wildlife. Exposure to EDCs is ubiquitous and occurs through contaminated food and water, air, consumer products, and transfer from parents to offspring. Effective regulation has been challenging due to a limited understanding of EDCs' complex and nonlinear dose-response relationships, as well as difficulty in attributing specific health effects to individual EDC exposures in real-world scenarios. Current EDC policies face limitations in terms of the diversity and complexity of EDCs, the lack of comprehensive testing requirements, and the need for more robust regulatory frameworks that consider cumulative and mixture effects of EDCs. Understanding these aspects is crucial for developing effective and evidence-based EDC policies that can safeguard public health and the environment.

Indexed as

endocrine-disrupting chemical (EDC)Environmental Protection Agencyepigeneticspublic healthregulatory policyreproduction

Identifiers

PMID39758979
PMCPMC11698485

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.